SG Americas Securities’s Aravive, Inc. Common Stock ARAV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-6,520
Closed -$86K 3622
2017
Q4
$86K Buy
6,520
+4,608
+241% +$59.3K ﹤0.01% 2889
2017
Q3
$28K Buy
+1,912
New +$193K ﹤0.01% 3382
2017
Q2
Sell
-1,237
Closed -$158K 3601
2017
Q1
$158K Sell
1,237
-1,027
-45% -$108K ﹤0.01% 2626
2016
Q4
$202K Buy
+2,264
New +$172K ﹤0.01% 2341
2015
Q1
Sell
-746
Closed -$101K 3154
2014
Q4
$101K Buy
+746
New +$87.3K ﹤0.01% 2921

Other funds holding ARAV

SG Americas Securities's ARAV Position: Q1 2018 in Review

SG Americas Securities sold out of Aravive, Inc. Common Stock (ARAV) in Q1 2018, closing a stake of 6,520 shares — an estimated $86K sold.

SG Americas Securities first reported a position in ARAV in Q4 2014 and held it in 5 quarters. The position peaked at $202K in Q4 2016. 69 funds tracked by Wall St. Rank hold ARAV as of Q1 2018.

  • SG Americas Securities reported no remaining Aravive, Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • SG Americas Securities sold 6,520 Aravive, Inc. Common Stock shares in Q1 2018, an estimated $86K.
  • SG Americas Securities first reported a position in Aravive, Inc. Common Stock in Q4 2014 and held it in 5 quarters.
  • SG Americas Securities's Aravive, Inc. Common Stock position peaked at $202K in Q4 2016.
  • 69 funds tracked by Wall St. Rank held Aravive, Inc. Common Stock as of Q1 2018.

Based on SG Americas Securities's 13F filing for Q1 2018, filed 3 May 2018.